Bipolar Disorder and Addiction: What Families Need to Know

Bipolar disorder and substance use disorder are two of the most commonly co-occurring conditions in behavioral health, and their overlap is not coincidental. Epidemiological data consistently shows that people with bipolar I disorder have a lifetime prevalence of alcohol use disorder of approximately 46% and any substance use disorder approaching 60%. For bipolar II, the rates are somewhat lower but still markedly elevated above the general population.

For families, this co-occurrence is a clinical problem with real consequences. The person who cycles between mania and depression is often also the person who drinks heavily or uses substances in ways that are hard to separate from the mood episodes. When does the substance use cause the mood instability? When does the mood instability drive the substance use? The answer is usually: both, simultaneously, reinforcing each other in ways that make standard treatment approaches insufficient.

Why Bipolar Disorder and Substance Use Co-Occur

Several mechanisms explain the high co-occurrence rate, and understanding them changes how families interpret what they are watching.

Self-medication

The most commonly recognized pathway: a person in the depressive phase of bipolar disorder uses alcohol or stimulants to manage the flatness, the anhedonia, the inability to initiate. A person in a hypomanic or manic state may use alcohol or benzodiazepines to dampen the intensity, to sleep, to come down. The substance use is not random — it is often targeted at specific symptoms, which is why it appears to work in the short term and why it is so hard to interrupt.

Shared neurobiological vulnerability

Research into the neurobiology of both conditions points toward shared dysregulation of dopamine, serotonin, and the brain's reward and stress-response systems. People with bipolar disorder may have a neurobiological vulnerability to addiction that goes beyond self-medication — the same circuits that produce mood dysregulation appear to contribute to elevated sensitivity to reward and impaired inhibitory control, both of which increase addiction risk.

Substance use precipitating or worsening mood episodes

Alcohol is a depressant that can deepen and extend depressive episodes. Stimulants — cocaine, methamphetamine, even heavy cannabis use in vulnerable individuals — can trigger or prolong manic or psychotic episodes. Once the substance use is established, it can take on a life of its own that is independent of the original self-medication function. The person is now managing both a mood disorder and a substance use disorder, each of which is actively worsening the other.

Why Standard Treatment Often Fails

Most treatment programs are built for one disorder. A psychiatric program focused on bipolar stabilization may stabilize the mood — but if it does not address the substance use, the person returns to using and destabilizes within weeks. A substance use treatment program may achieve short-term sobriety — but if the underlying bipolar disorder is untreated or misdiagnosed, the mood cycles continue and become the primary trigger for relapse.

The diagnostic picture is also genuinely complex. Substance use can produce mood symptoms that look exactly like bipolar disorder — sustained periods of elevated mood, decreased sleep, and impulsive behavior during active stimulant use; sustained depression, anhedonia, and suicidality during heavy alcohol use or opioid withdrawal. A psychiatric evaluation conducted during active substance use or acute withdrawal may yield a diagnosis that does not accurately reflect the underlying condition.

This is why the timing and sequencing of assessment matters. The most accurate psychiatric picture emerges after a period of sustained abstinence — typically 30 to 90 days, depending on what substances are involved. A diagnosis made at day 3 of sobriety may be wrong. A diagnosis made at day 60 with a complete history is far more reliable.

Families often come to us after watching their loved one cycle through multiple treatment programs — each of which addressed one condition without adequately treating the other. The pattern is predictable and the frustration is legitimate.

What Integrated Treatment Actually Means

Integrated dual diagnosis treatment means that a single treatment team addresses both the bipolar disorder and the substance use disorder simultaneously, within the same program, with coordinated clinical oversight. It is meaningfully different from sequential treatment — first addressing one, then the other — or parallel treatment, where two separate programs run independently.

The research is clear on this. A 2015 Cochrane review found that integrated treatments outperformed standard care on both substance use outcomes and psychiatric symptoms for people with co-occurring serious mental illness and substance use disorders. The advantage held across multiple study designs and populations.

In practice, integrated treatment for bipolar disorder and substance use disorder involves:

• Psychiatric evaluation and medication management that accounts for the substance use history and ongoing sobriety status.
• Individual therapy addressing both mood regulation and substance use — typically involving evidence-based approaches such as Cognitive Behavioral Therapy (CBT) for bipolar disorder, Motivational Interviewing (MI), and relapse prevention work that accounts for mood episodes as high-risk triggers.
• Psychoeducation for the person about both conditions, particularly the relationship between mood states and substance use patterns.
• Family involvement, when appropriate and clinically indicated.
• A monitoring and relapse prevention plan that accounts for the interaction between the two conditions — because a mood episode is a substance use risk, and a substance use relapse is a mood episode risk.

Medication Considerations

Mood stabilization is a central goal of bipolar treatment, and medication is typically a component of that. For families, a few medication considerations are clinically relevant.

Not all mood stabilizers carry the same risk profile in the context of substance use. Lithium, valproate (Depakote), and lamotrigine (Lamictal) are among the most common mood stabilizers used for bipolar disorder. Medication adherence is significantly harder to maintain during active substance use, and substance use can affect therapeutic levels of medications like lithium. A prescribing psychiatrist who understands the co-occurring picture is essential.

Benzodiazepines, which are sometimes prescribed for acute anxiety or agitation in bipolar disorder, carry real addiction risk in this population given the elevated substance use vulnerability. A psychiatrist aware of the full clinical picture typically approaches benzodiazepine prescribing with caution in this population.

Medication is not the whole answer. But inadequate psychiatric treatment — because the substance use disorder was not disclosed, was minimized, or was treated as a moral failing rather than a clinical condition — is one of the most common reasons bipolar treatment fails.

What Families Can Do

The family's role in navigating bipolar disorder and co-occurring addiction is genuinely difficult — and families often receive conflicting guidance from different parts of the treatment system. A few things are consistently useful:

• Insist on a program that treats both. When evaluating treatment options, ask directly: does your program treat co-occurring bipolar disorder and substance use disorder simultaneously, with a single integrated clinical team? Not "do you treat both" — those are different questions.
• Provide complete history. The clinical picture is shaped by what the evaluating clinician knows. Prior hospitalizations, medication trials, patterns of substance use across mood states, family psychiatric history — all of this is relevant. Write it down before the evaluation.
• Do not assume one has been resolved when the other is still active. If your loved one achieves sobriety but the mood disorder remains untreated, relapse is likely. If the mood disorder is stabilized but the substance use is minimized or not addressed, the substance use will continue to destabilize mood.
• Plan for high-risk windows. Mood episodes — particularly depressive episodes — are predictable periods of elevated substance use risk. A relapse prevention plan that identifies these windows and puts clinical support in place during them is meaningfully different from a plan that assumes stable mood.

For a full overview of how co-occurring conditions are assessed and treated, see our page on co-occurring disorders case management.

Frequently Asked Questions

Can bipolar disorder cause substance use disorder?

The relationship is bidirectional. Bipolar disorder creates neurobiological vulnerability to addiction and creates circumstances — depression, mania, insomnia, dysphoria — that drive self-medication. Substance use, in turn, can trigger and worsen mood episodes. In most cases, neither condition cleanly "caused" the other; they are mutually reinforcing and need to be addressed together.

How do you accurately diagnose bipolar disorder when someone is using substances?

The most accurate psychiatric picture requires a period of sustained abstinence — typically 30 to 90 days depending on the substances involved. A diagnosis made during active use or acute withdrawal may not be reliable because many substances produce mood symptoms that mimic bipolar disorder. A comprehensive psychiatric evaluation after a period of sobriety, combined with a full longitudinal history (including patterns before substance use began), is the most clinically valid approach.

Should someone with bipolar disorder avoid all medications used in addiction treatment?

No. There are FDA-approved medications for alcohol use disorder (naltrexone, acamprosate) and opioid use disorder (buprenorphine, naltrexone) that do not interfere with bipolar treatment. The question is whether the prescribing clinician has the full clinical picture. A psychiatrist who knows the substance use history and is coordinating with the treating addiction clinician is the appropriate model — not two separate prescribers working independently.

Is it safe to be in AA or NA with a bipolar diagnosis?

12-step programs can be valuable peer support for many people with co-occurring bipolar disorder and addiction — the community, structure, and accountability are clinically meaningful. The potential complication is that some 12-step communities have historically had mixed attitudes toward psychiatric medication, with some members suggesting that taking medication conflicts with "real" sobriety. This is not clinically supported. People with bipolar disorder who take prescribed mood stabilizers are not compromising their sobriety. A therapist or case manager familiar with both the treatment world and the 12-step world can help navigate this if it becomes an issue.

What is the prognosis for someone with both bipolar disorder and addiction?

Outcomes are meaningfully better when both conditions are treated simultaneously by a coordinated clinical team. Research consistently shows that integrated treatment produces better results on both substance use outcomes and psychiatric stability than treating either condition alone. The prognosis for co-occurring bipolar disorder and addiction is not worse by definition — it is worse when the treatment is fragmented. Families who advocate for genuinely integrated care improve the clinical picture significantly.

If your family is navigating co-occurring bipolar disorder and addiction, contact us for a confidential consultation. All inquiries are confidential.